Hepatopulmonary Syndrome
- PMID: 32965840
- Bookshelf ID: NBK562169
Hepatopulmonary Syndrome
Excerpt
Hepatopulmonary syndrome was first proposed in 1977 based on autopsy and clinical findings. Autopsies showed dilated pulmonary vasculature in patients with liver cirrhosis and were thought to cause some of the pulmonary manifestations seen in patients with chronic liver disease. Hepatopulmonary syndrome is defined as reduced arterial oxygen saturation due to dilated pulmonary vasculature in the presence of advanced liver disease or portal hypertension.
Diagnostic Criteria
The diagnostic criteria for hepatopulmonary syndrome include:
Partial pressure of oxygen (PaO2): Defined as <80 mm Hg while breathing room air or alveolar-arterial oxygen gradient (A-aO2), ≥15 mm Hg while breathing room air. In patients older than 64, A-aO2 >20 mm Hg is considered diagnostic (these patients should be resting in a seated position).
Pulmonary vascular dilatation: Dilatation as shown by a positive contrast-enhanced echocardiography or by radioactive lung-perfusion scanning (demonstrating a brain shunt fraction of >6%).
Portal hypertension: Elevated pressure within the portal venous system with or without cirrhosis.
The severity of hepatopulmonary syndrome is classified based on the following PaO2 levels:
Mild: PaO2 ≥80 mm Hg with A-aO2 ≥15 mm Hg while breathing room air
Moderate: PaO2 ≥60 mm Hg to <80 mm Hg with A-aO2 ≥15 mm Hg while breathing room air
Severe: PaO2 ≥50 mm Hg to <60 mm Hg with A-aO2 ≥15 mm Hg while breathing room air
Very severe: PaO2 <50 mm Hg with A-aO2 ≥15 mm Hg while breathing room air, or PaO2 <300 mm Hg while breathing 100% oxygen
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Kennedy TC, Knudson RJ. Exercise-aggravated hypoxemia and orthodeoxia in cirrhosis. Chest. 1977 Sep;72(3):305-9. - PubMed
-
- Krowka MJ, Fallon MB, Kawut SM, Fuhrmann V, Heimbach JK, Ramsay MA, Sitbon O, Sokol RJ. International Liver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension. Transplantation. 2016 Jul;100(7):1440-52. - PubMed
-
- Rodríguez-Roisin R, Krowka MJ. Hepatopulmonary syndrome--a liver-induced lung vascular disorder. N Engl J Med. 2008 May 29;358(22):2378-87. - PubMed
-
- Fallon MB, Krowka MJ, Brown RS, Trotter JF, Zacks S, Roberts KE, Shah VH, Kaplowitz N, Forman L, Wille K, Kawut SM, Pulmonary Vascular Complications of Liver Disease Study Group Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates. Gastroenterology. 2008 Oct;135(4):1168-75. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources